Qiagen NV | QIA - Cost Of Sales


Qiagen NV reported $182.72M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
argenx SE USD 145M 24M Jun/2026
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Moderna USD 93M 862M Jun/2026
Organon & Co USD 677M 89M Mar/2026
Qiagen NV USD 182.72M 34.71M Mar/2026
Revvity USD 312.82M 10.64M Jun/2026
Viatris USD 2.3B 59.5M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026